日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structural basis of anticancer drug recognition and amino acid transport by LAT1

LAT1 识别抗癌药物和转运氨基酸的结构基础

Lee, Yongchan; Jin, Chunhuan; Ohgaki, Ryuichi; Xu, Minhui; Ogasawara, Satoshi; Warshamanage, Rangana; Yamashita, Keitaro; Murshudov, Garib; Nureki, Osamu; Murata, Takeshi; Kanai, Yoshikatsu

ABCF1-K430-Lactylation promotes HCC malignant progression via transcriptional activation of HIF1 signaling pathway.

ABCF1-K430-乳酸化通过HIF1信号通路的转录激活促进HCC恶性进展

Hong Han, Han Hexu, Wang Lei, Cao Wen, Hu Minjie, Li Jindong, Wang Jiawei, Yang Yijin, Xu XiaoYong, Li Gaochao, Zhang Zixiang, Zhang Changhe, Xu Minhui, Wang Honggang, Wang Qiang, Yuan Yin

Long-Term Estimated Physical Activity Patterns From Youth to Middle Age and Left Ventricular Structure and Function: A 30-Year Longitudinal Study

从青少年到中年,长期身体活动模式与左心室结构和功能的关系:一项为期30年的纵向研究

Li, Shunyi; Luo, Jianpin; Zhao, Shen; Zhou, Haobin; Xi, Rongyang; Chen, Jun; Li, Shichao; Li, Kaiwei; Song, Lin; Duan, Xiaolin; Xu, Minhui; Xu, Dingli; Zeng, Qingchun

Association between estimated glucose disposal rate and the risk of MAFLD in American adults: a cross-sectional study

美国成年人估计葡萄糖处置率与代谢相关脂肪性肝病风险之间的关联:一项横断面研究

Zhou, Yuhang; Wang, Bang; Wu, Miaoxin; Hong, Han; Li, Gaochao; Xu, Minhui

Pharmacological and structural insights into nanvuranlat, a selective LAT1 (SLC7A5) inhibitor, and its N-acetyl metabolite with implications for cancer therapy

对选择性LAT1 (SLC7A5)抑制剂nanvuranlat及其N-乙酰代谢物的药理学和结构研究及其在癌症治疗中的意义

Jin, Chunhuan; Zhou, Xinyu; Xu, Minhui; Okanishi, Hiroki; Ohgaki, Ryuichi; Kanai, Yoshikatsu

Author Correction: The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2

作者更正:4F2抗原的重链通过SKP-2促进前列腺癌进展。

Maimaiti, Maihulan; Sakamoto, Shinichi; Sugiura, Masahiro; Kanesaka, Manato; Fujimoto, Ayumi; Matsusaka, Keisuke; Xu, Minhui; Ando, Keisuke; Saito, Shinpei; Wakai, Ken; Imamura, Yusuke; Nakayama, Keiichi; Kanai, Yoshikatsu; Kaneda, Atsushi; Ikehara, Yuzuru; Ikeda, Jun-Ichiro; Anzai, Naohiko; Ichikawa, Tomohiko

Evolutionary diversification and expressional profile of adrenergic receptors in the Pacific oyster Crassostrea gigas

太平洋牡蛎(Crassostrea gigas)肾上腺素能受体的进化多样化和表达谱

Xu, Minhui; Gao, Xiaolong; Dong, Miren; Wang, Lingling; Wang, Chunlin

Transcriptomic Analysis Provides Insights into Candidate Genes and Molecular Pathways Involved in Growth of Mytilus coruscus Larvae

转录组分析揭示了参与贻贝幼虫生长发育的候选基因和分子通路

Xu, Minhui; Li, Zhong; Liang, Xinjie; Li, Jiji; Ye, Yingying; Qi, Pengzhi; Yan, Xiaojun

L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity

L型氨基酸转运蛋白1抑制剂JPH203通过抑制细胞周期蛋白依赖性激酶活性来阻止卡巴他赛耐药性前列腺癌的生长。

Rii, Junryo; Sakamoto, Shinichi; Mizokami, Atsushi; Xu, Minhui; Fujimoto, Ayumi; Saito, Shinpei; Koike, Hidekazu; Tamura, Takaaki; Arai, Takayuki; Yamada, Yasutaka; Goto, Yusuke; Sazuka, Tomokazu; Imamura, Yusuke; Suzuki, Kazuhiro; Kanai, Yoshikatsu; Anzai, Naohiko; Ichikawa, Tomohiko

The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism

LAT1抑制剂JPH203通过CD24介导的机制抑制去势抵抗性前列腺癌的生长。

Saito, Shinpei; Ando, Keisuke; Sakamoto, Shinichi; Xu, Minhui; Yamada, Yasutaka; Rii, Junryo; Kanaoka, Sanji; Wei, Jiaxing; Zhao, Xue; Pae, Sangjon; Kanesaka, Manato; Goto, Yusuke; Sazuka, Tomokazu; Imamura, Yusuke; Reien, Yoshie; Hamaguchi-Suzuki, Norie; Saito, Shota; Hirayama, Yuri; Hashimoto, Hirofumi; Kanai, Yoshikatsu; Ichikawa, Tomohiko; Anzai, Naohiko